Thomas Cherian

519 total citations
23 papers, 283 citations indexed

About

Thomas Cherian is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Thomas Cherian has authored 23 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 10 papers in Public Health, Environmental and Occupational Health and 5 papers in Epidemiology. Recurrent topics in Thomas Cherian's work include Streptococcal Infections and Treatments (8 papers), Antimicrobial Resistance in Staphylococcus (6 papers) and Viral Infections and Outbreaks Research (4 papers). Thomas Cherian is often cited by papers focused on Streptococcal Infections and Treatments (8 papers), Antimicrobial Resistance in Staphylococcus (6 papers) and Viral Infections and Outbreaks Research (4 papers). Thomas Cherian collaborates with scholars based in United States, United Kingdom and Australia. Thomas Cherian's co-authors include Daniel R. Feikin, Ann Lindstrand, Katherine L. O’Brien, Alexandros Giakoustidis, Dimitrios Giakoustidis, Nikolaos Antoniadis, Mohamed Rela, Chris Van Beneden, Jonathan R. Carapetis and Asha C Bowen and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Journal of Ethnopharmacology.

In The Last Decade

Thomas Cherian

21 papers receiving 263 citations

Peers

Thomas Cherian
Mandyam Dhati Ravi India
Marios Lazanas Greece
Niklas Danielsson Sweden
Lakshmi Sukumaran United States
Azza Galal Farghaly Egypt
Sameera Pathirannehelage United Kingdom
Chathika K. Weerasuriya United Kingdom
Derek Ehrhardt United States
Bruce Gutelius United States
Analía Urueña Argentina
Mandyam Dhati Ravi India
Thomas Cherian
Citations per year, relative to Thomas Cherian Thomas Cherian (= 1×) peers Mandyam Dhati Ravi

Countries citing papers authored by Thomas Cherian

Since Specialization
Citations

This map shows the geographic impact of Thomas Cherian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Cherian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Cherian more than expected).

Fields of papers citing papers by Thomas Cherian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Cherian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Cherian. The network helps show where Thomas Cherian may publish in the future.

Co-authorship network of co-authors of Thomas Cherian

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Cherian. A scholar is included among the top collaborators of Thomas Cherian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Cherian. Thomas Cherian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilder‐Smith, Annelies, Thomas Cherian, & Joachim Hombach. (2025). Dengue Vaccine Development and Deployment into Routine Immunization. Vaccines. 13(5). 483–483. 4 indexed citations
2.
Scheel, Amy, Andrea Beaton, Judith Katzenellenbogen, et al.. (2022). Standardization of Epidemiological Surveillance of Rheumatic Heart Disease. Open Forum Infectious Diseases. 9(Supplement_1). S50–S56. 2 indexed citations
3.
Scheel, Amy, Andrea Beaton, Judith Katzenellenbogen, et al.. (2022). Standardization of Epidemiological Surveillance of Acute Rheumatic Fever. Open Forum Infectious Diseases. 9(Supplement_1). S41–S49. 2 indexed citations
4.
Carapetis, Jonathan R., Thomas Cherian, Roderick J. Hay, et al.. (2022). Standardization of Epidemiological Surveillance of Group A Streptococcal Impetigo. Open Forum Infectious Diseases. 9(Supplement_1). S15–S24. 1 indexed citations
5.
Lamagni, Theresa, Roderick J. Hay, Jeffrey Cannon, et al.. (2022). Standardization of Epidemiological Surveillance of Group A Streptococcal Cellulitis. Open Forum Infectious Diseases. 9(Supplement_1). S25–S30. 3 indexed citations
6.
Lamagni, Theresa, Thomas Cherian, Jeffrey Cannon, et al.. (2022). Standardization of Epidemiological Surveillance of Invasive Group A Streptococcal Infections. Open Forum Infectious Diseases. 9(Supplement_1). S31–S40. 17 indexed citations
7.
Tanz, Robert R., Stanford T. Shulman, Jonathan R. Carapetis, et al.. (2022). Standardization of Epidemiological Surveillance of Group A Streptococcal Pharyngitis. Open Forum Infectious Diseases. 9(Supplement_1). S5–S14. 8 indexed citations
8.
Beneden, Chris Van, Malcolm McDonald, William Wong, et al.. (2022). Standardization of Epidemiological Surveillance of Acute Poststreptococcal Glomerulonephritis. Open Forum Infectious Diseases. 9(Supplement_1). S57–S64. 5 indexed citations
9.
Moore, Hannah C., Jeffrey Cannon, David C. Kaslow, et al.. (2022). A Systematic Framework for Prioritizing Burden of Disease Data Required for Vaccine Development and Implementation: The Case for Group A Streptococcal Diseases. Clinical Infectious Diseases. 75(7). 1245–1254. 11 indexed citations
10.
Lindstrand, Ann, et al.. (2021). The World of Immunization: Achievements, Challenges, and Strategic Vision for the Next Decade. The Journal of Infectious Diseases. 224(Supplement_4). S452–S467. 84 indexed citations
11.
Malvolti, Stefano, Thomas Cherian, Noni E. MacDonald, et al.. (2020). Global Vaccine Action Plan Lessons Learned II: Stakeholder Perspectives. Vaccine. 38(33). 5372–5378. 11 indexed citations
12.
Cherian, Thomas, Carsten Mantel, Stefano Malvolti, et al.. (2020). Global Vaccine Action Plan lessons learned III: Monitoring and evaluation/accountability framework. Vaccine. 38(33). 5379–5383. 12 indexed citations
13.
Cherian, Thomas, Narendra K. Arora, & Noni E. MacDonald. (2020). The global vaccine action plan monitoring and evaluation/accountability framework: Perspective. Vaccine. 38(33). 5384–5386. 2 indexed citations
14.
Cherian, Thomas, Piyush Gupta, & Kurien Thomas. (2020). An External Evaluation on the INCLEN Research Program to Emphasize the Public Health Significance of Childhood Pneumonia in India. Indian Pediatrics. 58(11). 1074–1076.
15.
Varghese, Joy, Mettu Srinivas Reddy, Thomas Cherian, et al.. (2014). Anti-HBs response to hepatitis B immunoglobulin prophylaxis in liver transplant recipients. Indian Journal of Gastroenterology. 33(3). 226–230. 4 indexed citations
16.
Varghese, Joy, et al.. (2013). Anti HBs antibody level in response to hepatitis B immunoglobulin (HBIG) prophylaxis in liver transplant recipients. Journal of Clinical and Experimental Hepatology. 3(1). S112–S112. 1 indexed citations
17.
Cherian, Thomas, Alexandros Giakoustidis, Satoshi Yokoyama, et al.. (2012). Treatment of Refractory Cerebral Aspergillosis in a Liver Transplant Recipient With Voriconazole: Case Report and Review of the Literature. Experimental and Clinical Transplantation. 10(5). 482–486. 7 indexed citations
18.
Cherian, Thomas, K.W. Chiu, Bridget Gunson, et al.. (2010). Pulmonary thromboembolism in liver transplantation: a retrospective review of the first 25 years. Transplant International. 23(11). 1113–1119. 24 indexed citations
19.
Dar, Faisal Saud, et al.. (2010). Liver transplantation for acute intermittent porphyria: a viable treatment?. PubMed. 9(1). 93–6. 19 indexed citations
20.
Cherian, Thomas. (2000). Effect of papaya latex extract on gravid and non-gravid rat uterine preparations in vitro. Journal of Ethnopharmacology. 70(3). 205–212. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mandyam Dhati Ravi Breakdown of academic impact, for papers by Marios Lazanas Breakdown of academic impact, for papers by Niklas Danielsson Breakdown of academic impact, for papers by Lakshmi Sukumaran Breakdown of academic impact, for papers by Azza Galal Farghaly Breakdown of academic impact, for papers by Sameera Pathirannehelage Breakdown of academic impact, for papers by Chathika K. Weerasuriya Breakdown of academic impact, for papers by Derek Ehrhardt Breakdown of academic impact, for papers by Bruce Gutelius Breakdown of academic impact, for papers by Analía Urueña
Rankless by CCL
2026